{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:58:49Z","timestamp":1791464329176,"version":"4.3.4"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023044","name":"Commonwealth of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023044","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI160664"],"award-info":[{"award-number":["U01 AI160664"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F31 AI179240"],"award-info":[{"award-number":["F31 AI179240"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI157247"],"award-info":[{"award-number":["R01 AI157247"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI148249"],"award-info":[{"award-number":["R01 AI148249"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 CA009140"],"award-info":[{"award-number":["T32 CA009140"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.celrep.2025.115840","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:06:38Z","timestamp":1749726398000},"page":"115840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["De-coupling immune parameters and toxicity associated with IL-12 agonism"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7229-0973","authenticated-orcid":false,"given":"Zachary R.","family":"Lanzar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargavi","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanne","family":"Haskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathya","family":"Arana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly E.","family":"Bunkofske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Mulka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Pardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Byerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Striepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lupardus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.115840_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The Immunobiology of the Interleukin-12 Family: Room for Discovery","volume":"50","author":"Tait Wojno","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.115840_bib3","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1073\/pnas.90.13.6115","article-title":"Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts","volume":"90","author":"Gazzinelli","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.115840_bib4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0167-5699(94)90189-9","article-title":"The role of interleukin 12 in the immune response, disease and therapy","volume":"15","author":"Trinchieri","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.celrep.2025.115840_bib5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/CMR.10.4.611","article-title":"Interleukin-12 in infectious diseases","volume":"10","author":"Romani","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.celrep.2025.115840_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020167","article-title":"IL-12 Family Cytokines in Cancer and Immunotherapy","volume":"13","author":"Mirlekar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.celrep.2025.115840_bib7","first-page":"326","article-title":"An optimized IL-12-Fc expands its therapeutic window, achieving strong activity against mouse tumors at tolerable drug doses","volume":"4","author":"Gutierrez","year":"2023","journal-title":"M\u00e9d. Sur"},{"key":"10.1016\/j.celrep.2025.115840_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100053","article-title":"The multifaceted role of IL-12 in cancer","volume":"5","author":"Habiba","year":"2022","journal-title":"Advances in Cancer Biology - Metastasis"},{"key":"10.1016\/j.celrep.2025.115840_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/019262339902700112","article-title":"The Toxicology of Interleukin-12 - A Review","volume":"27","author":"Car","year":"1999","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.celrep.2025.115840_bib10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1126\/science.270.5238.908.a","article-title":"IL-12 deaths: explanation and a puzzle","volume":"270","author":"Cohen","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115840_bib11","first-page":"2541","article-title":"Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12\u2013Associated Toxicity and Interferon-\u03b3 Production","volume":"90","author":"John","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.115840_bib12","first-page":"409","article-title":"Phase I evaluation of intavenous recombinantn human interleukin 12 in patients with advanced malignancies","volume":"3","author":"Atkins","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2025.115840_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1365-2249.2000.01112.x","article-title":"Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients","volume":"119","author":"Haicheur","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1479-5876-5-66","article-title":"Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma","volume":"5","author":"Lenzi","year":"2007","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.celrep.2025.115840_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0092-8674(89)90121-9","article-title":"Pleiotropy and Redundancy- T Cell-Derived Lymphokines in the Immune Response","volume":"57","author":"Paul","year":"1989","journal-title":"Cell (Cambridge, MA, U. S.)"},{"key":"10.1016\/j.celrep.2025.115840_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/ITT.S306150","article-title":"NHS-IL12, a Tumor-Targeting Immunocytokine","volume":"10","author":"Greiner","year":"2021","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.celrep.2025.115840_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41551-020-0549-2","article-title":"Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours","volume":"4","author":"Mansurov","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2025.115840_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adm8451","article-title":"Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70","volume":"16","author":"Brook","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.115840_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.omtn.2023.07.020","article-title":"Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure","volume":"33","author":"Di Trani","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.celrep.2025.115840_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","article-title":"Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity","volume":"19","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.celrep.2025.115840_bib21","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1038\/s41598-024-57997-w","article-title":"Intravenous administration of IL-12 encoding self-replicating RNA-lipid nanoparticle complex leads to safe and effective antitumor responses","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2025.115840_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2022.03.021","article-title":"Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy","volume":"345","author":"Liu","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.celrep.2025.115840_bib23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41551-022-00888-0","article-title":"Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker","volume":"6","author":"Mansurov","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2025.115840_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575597","article-title":"Localized Interleukin-12 for Cancer Immunotherapy","volume":"11","author":"Nguyen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib25","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1182\/blood-2021-152758","article-title":"Conditionally Activated IL-12 or IFN\u03b1 Indukine\u2122 Molecules Inhibit Syngeneic Lymphoma Tumor Growth in Mice, Induce Anti-Tumor Immune Responses and Are Tolerated in Non-Human Primates","volume":"138","author":"Steiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.115840_bib26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.185.5.817","article-title":"Regulation of the Interleukin (IL)-12R \u03b22 Subunit Expression in Developing T Helper 1 (Th1) and Th2 Cells","volume":"185","author":"Szabo","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.115840_bib27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cell.2021.01.018","article-title":"Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells","volume":"184","author":"Glassman","year":"2021","journal-title":"Cell (Cambridge, MA, U. S.)"},{"key":"10.1016\/j.celrep.2025.115840_bib28","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1084\/jem.181.5.1893","article-title":"The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo","volume":"181","author":"Eng","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.115840_bib29","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1182\/blood.V85.9.2371.bloodjournal8592371","article-title":"Interleukin-12 enhances peripheral hematopoiesis in vivo","volume":"85","author":"Jackson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2025.115840_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/BS9.0000000000000002","article-title":"Interleukin-12 supports in vitro self-renewal of long-term hematopoietic stem cells","volume":"1","author":"Zhang","year":"2019","journal-title":"Blood Sci."},{"key":"10.1016\/j.celrep.2025.115840_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104197","article-title":"Interferon-gamma increases monocyte PD-L1 but does not diminish T-cell activation","volume":"357","author":"Galbraith","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib32","article-title":"Upregulation of programmed cell death 1 by interferon gamma and its biological functions in human monocytes","volume":"32","author":"Sri-Ngern-Ngam","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.celrep.2025.115840_bib33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature06672","article-title":"Memory CD4 T cells emerge from effector T-cell progenitors","volume":"452","author":"Harrington","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115840_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47605","article-title":"Toxoplasma gondii infection drives conversion of NK cells into ILC1-like cells","volume":"8","author":"Park","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2025.115840_bib35","article-title":"Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-gamma, IL-2 and IL-2R","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2025.115840_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.immuni.2012.05.031","article-title":"T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor beta2","volume":"37","author":"Koch","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.115840_bib37","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.4049\/jimmunol.162.8.4943","article-title":"A Fatal Cytokine-Induced Systemic Inflammatory Response Reveals a Critical Role for NK Cells","volume":"162","author":"Carson","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib38","article-title":"Anti-Asialo GM1 treatment during secondary Toxoplasma gondii infection is lethal and depletes T cells","author":"Ivanova","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2025.115840_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/cmi.2015.115","article-title":"NKT cell subsets as key participants in liver physiology and pathology","volume":"13","author":"Bandyopadhyay","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1035950","article-title":"New insights into iNKT cells and their roles in liver diseases","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.it.2024.05.008","article-title":"Innate-like T cells in liver disease","volume":"45","author":"Yang","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib42","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4049\/jimmunol.165.2.628","article-title":"Cutting Edge: IL-12 Is Required for the Maintenance of IFN- Production in T Cells Mediating Chronic Resistance to the Intracellular Pathogen, Toxoplasma gondii","volume":"165","author":"Yap","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.exppara.2006.07.001","article-title":"Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice","volume":"115","author":"Ehigiator","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.celrep.2025.115840_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-023-00932-3","article-title":"Immunity to Cryptosporidium: insights into principles of enteric responses to infection","volume":"24","author":"Pardy","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib45","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.153.6.2533","article-title":"Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii","volume":"153","author":"Gazzinelli","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib46","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232067","article-title":"Intestinal cDC1s provide cues required for CD4+ T cell-mediated resistance to Cryptosporidium","volume":"221","author":"Cohn","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.celrep.2025.115840_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.mucimm.2024.03.003","article-title":"Dendritic cell-mediated responses to secreted Cryptosporidium effectors promote parasite-specific CD8+T cell responses","volume":"17","author":"Haskins","year":"2024","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173107","article-title":"A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models","volume":"134","author":"Efe","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.115840_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba5264","article-title":"An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice","volume":"5","author":"Khoryati","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib50","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41590-023-01428-x","article-title":"Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs","volume":"24","author":"Wang","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity \u2014 basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.celrep.2025.115840_bib52","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1128\/iai.65.5.1675-1682.1997","article-title":"Hunter. . Role of Interleukin-10 in Regulation of T-Cell-Dependent and T-Cell-Independent Mechanisms of Resistance to Toxoplasma gondii","volume":"65","author":"Lauria Ellis Neyer","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2025.115840_bib53","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4049\/jimmunol.156.3.1138","article-title":"An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections","volume":"156","author":"Orange","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib54","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.4049\/jimmunol.162.10.5894","article-title":"IL-18 and CD28 Use Distinct Molecular Mechanisms to Enhance NK Cell Production of IL-12-Induced IFN-\u03b31","volume":"162","author":"Walker","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib55","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.4049\/jimmunol.1600037","article-title":"IL-12 Signals through the TCR To Support CD8 Innate Immune Responses","volume":"197","author":"Goplen","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.180.1.211","article-title":"Interleukin 12 synergizes with B7\/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells","volume":"180","author":"Kubin","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.115840_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania major","volume":"263","author":"Afonso","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115840_bib58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/smim.1997.0084","article-title":"IL-12 as an adjuvant for cell-mediated immunity","volume":"9","author":"Scott","year":"1997","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib59","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00262-022-03144-1","article-title":"Interleukin-12 as an in situ cancer vaccine component: a review","volume":"71","author":"Cheng","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2025.115840_bib60","first-page":"1","article-title":"The activation of bystander CD8(+) T cells and their roles in viral infection","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celrep.2025.115840_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41590-021-00985-3","article-title":"Significance of bystander T cell activation in microbial infection","volume":"23","author":"Lee","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5483\/BMBRep.2022.55.2.183","article-title":"Emerging role of bystander T cell activation in autoimmune diseases","volume":"55","author":"Shim","year":"2022","journal-title":"BMB Rep."},{"key":"10.1016\/j.celrep.2025.115840_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162800","article-title":"Memory T cells possess an innate-like function in local protection from mucosal infection","volume":"133","author":"Arkatkar","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.115840_bib64","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1128\/IAI.70.12.6940-6947.2002","article-title":"Contribution of interleukin-12 (IL-12) and the CD28\/B7 and CD40\/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice","volume":"70","author":"Wille","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2025.115840_bib65","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1359-6101(98)00017-3","article-title":"IL-12 and viral infections","volume":"9","author":"Komastu","year":"1998","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.celrep.2025.115840_bib66","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.3390\/ijms24087350","article-title":"Potential of Interleukin (IL)-12 Group as Antivirals: Severe Viral Disease Prevention and Management","volume":"24","author":"NA","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2025.115840_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/science.abi9591","article-title":"KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19","volume":"376","author":"Li","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.115840_bib72","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2025.115840_bib73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-1759(93)90361-A","article-title":"Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen: Cytokine detection by immunoassay and intracellular immunostraining","volume":"166","author":"Sander","year":"1993","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2025.115840_bib68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2019.05.006","article-title":"A Genetically Tractable, Natural Mouse Model of Cryptosporidiosis Offers Insights into Host Protective Immunity","volume":"26","author":"Sateriale","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2025.115840_bib69","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis","volume":"546","author":"Manjunatha","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.115840_bib70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molimm.2015.02.017","article-title":"Crystal structures of immunoglobulin Fc heterodimers reveal the molecular basis for heterodimer formation","volume":"65","author":"Choi","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/protein\/gzw040","article-title":"Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions","volume":"29","author":"Schlothauer","year":"2016","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.celrep.2025.115840_bib74","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2025.115840_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112147","article-title":"IL-18BP mediates the balance between protective and pathological immune responses to Toxoplasma gondii","volume":"42","author":"Clark","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.115840_bib76","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41590-022-01170-w","article-title":"PD-L1\u2013PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection","volume":"23","author":"Perry","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.115840_bib77","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41385-021-00468-6","article-title":"Enterocyte-innate lymphoid cell crosstalk drives early IFN-\u03b3-mediated control of Cryptosporidium","volume":"15","author":"Gullicksrud","year":"2022","journal-title":"Mucosal Immunol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725006114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725006114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:14:05Z","timestamp":1786652045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725006114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2211124725006114"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115840","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De-coupling immune parameters and toxicity associated with IL-12 agonism","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.115840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115840"}}